In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

Trilles, Luciana; Fernández-Torres, Belkys; Lazéra, Márcia dos Santos; Wanke, Bodo; Schubach, Armando de Oliveira; Paes, Rodrigo de Almeida; Inza, Isabel; Guarro, Josep

Article

Registro en:

TRILLES, Luciana et al. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrobial Agents and Chemotherapy, v. 49, n. 9, p. 3952-3954, Sept. 2005.

0066-4804

https://www.arca.fiocruz.br/handle/icict/33486

10.1128/AAC.49.9.3952-3954.2005

1098-6596

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8891236

Autor

Trilles, Luciana

Fernández-Torres, Belkys

Lazéra, Márcia dos Santos

Wanke, Bodo

Schubach, Armando de Oliveira

Paes, Rodrigo de Almeida

Inza, Isabel

Guarro, Josep

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35°C) exerted a significant influence on the MICs.

2019-12-13

Materias

Sporothrix schenckii

Antifungal susceptibilities

Mostrar el registro completo del ítem